.png)
Biodegradable Stents Market By Stent Type (coronary Artery Stent And Peripheral Artery Stents), Material (polymer Based And Metal Based), End Users (hospitals, Cardiac Catheterization Laboratories, And Ambulatory Surgery Centers)- Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 190 Category: Medical Devices Report Code : HC061035
SEGMENTS & REGIONS:
- By Stent Type: coronary Artery Stent And Peripheral Artery Stents
- Material: polymer Based And Metal Based
- End Users: hospitals, Cardiac Catheterization Laboratories, And Ambulatory Surgery Centers
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
The Biodegradable Stents Market was worth USD 14.13 million in 2017 and is expected to reach approximately USD 147.57 million by 2023, while registering itself at a compound annual growth rate (CAGR) of 29.78% during the forecast period. Biodegradable Stents are the third era of stents utilized as a part of the treatment of coronary conduit illnesses, which are totally invested in the body after the medication is eluted. The biodegradable stents have risen as an ideal substitution to the standard Medication Eluting Stents having a changeless polymer covering over them. Presentation of biodegradable stents has come about into diminishment in rates of thrombosis, in-stent restenosis, and double hostile to platelet treatment required with the DES and Uncovered Metal Stents, as the polymer or metal is totally caught up in the vessel, coming about into effective medication conveyance, and vascular reclamation. Players in the stents market are presently looking past the coronary and fringe conduit sickness treatment utilizations of the biodegradable stents after different clinical preliminaries which have exhibited the productivity of these biodegradable stents in other vascular intercessions.
Drivers & Restrains
In recent times, expanding commonness of coronary and fringe conduit illnesses is the key driver of the worldwide biodegradable stents market. Biodegradable stents stay away from stent-in-stent systems. They likewise kill the requirement for double against platelet treatments and treat coronary supply route infections more viably. Exact stent position and minimal effort treatment likewise pull in patients to receive biodegradable stents for sickness administration. However, moderate selection rate of stents in illness administration is the key restriction looked by the worldwide biodegradable stents market. High dangers of confusions related with biodegradable stents and high offering cost additionally hampers the market development. Likewise, insufficient repayment arrangements and nearness of substitutes are a portion of the real difficulties looked by the worldwide biodegradable stents market. Rising number of product dispatches and expanding mergers and acquisitions between key players are key patterns of this market.
Regional Outlook and Trend Analysis
North America is expected to witness considerable growth over the forecast period. In addition, innovative headways in biodegradable stents product is additionally supporting in the development of this market in North America. The U.S. speaks to the biggest market for biodegradable stents, trailed by Canada, in North America. In Europe, Germany, Italy, the U.K., and France holds significant offers of the biodegradable stents market. In any case, Asia is relied upon to display a high development rate in the following five years in the worldwide biodegradable stents market given the expanding open awareness about different coronary and fringe supply route sicknesses in the district. Japan, China, and India are required to be the quickest developing biodegradable stents market in Asia.
Competitive Insights
The leading players in the market are Abbott Laboratories, Boston Scientific, Inc., Kyoto Medical Planning, Biotronik, Elixir Medical Corporation and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Biodegradable Stents Market is segmented as follows-
By Stent Type:
- Coronary Artery Stents
- Peripheral Artery Stents
By Material:
- Polymer Based
- Metal Based
By End Users:
- Hospitals
- Cardiac Catheterization Laboratories
- Ambulatory Surgery Centre
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Biodegradable Stents Market, By Stent Type, Estimates and Forecast, 2014-2023($Billion)
o Coronary Artery Stents
o Peripheral Artery Stents
· Biodegradable Stents Market, By Material, Estimates and Forecast, 2014-2023($Billion)
o Polymer Based
o Metal Based
· Biodegradable Stents Market, By End User, Estimates and Forecast, 2014-2023($Billion)
o Hospitals
o Cardiac Catheterization Laboratories
o Ambulatory Surgery Centers
· Biodegradable Stents Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Biodegradable Stents Market, By Country
o U.S. Biodegradable Stents Market
o Canada Biodegradable Stents Market
o Mexico Biodegradable Stents Market
o Europe
§ Europe Biodegradable Stents Market, By Country
o Germany Biodegradable Stents Market
o UK Biodegradable Stents Market
o France Biodegradable Stents Market
o Russia Biodegradable Stents Market
o Italy Biodegradable Stents Market
o Rest of Europe Biodegradable Stents Market
o Asia-Pacific
§ Asia-Pacific Biodegradable Stents Market, By Country
o China Biodegradable Stents Market
o Japan Biodegradable Stents Market
o South Korea Biodegradable Stents Market
o India Biodegradable Stents Market
o Southeast Asia Biodegradable Stents Market
o Rest of Asia-Pacific Biodegradable Stents Market
o South America
§ South America Biodegradable Stents Market
o Brazil Biodegradable Stents Market
o Argentina Biodegradable Stents Market
o Columbia Biodegradable Stents Market
o South Africa Biodegradable Stents Market
o Rest of South America Biodegradable Stents Market
o Middle East and Africa
§ Middle East and Africa Biodegradable Stents Market
o Saudi Arabia Biodegradable Stents Market
o UAE Biodegradable Stents Market
o Egypt Biodegradable Stents Market
o Nigeria Biodegradable Stents Market
o South Africa Biodegradable Stents Market
o Rest of MEA Biodegradable Stents Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Biodegradable Stents Market, By Stent Type
5.1. Introduction
5.2. Global Biodegradable Stents Sales, Revenue and Market Share by Stent Type (2017-2027)
5.2.1. Global Biodegradable Stents Sales and Sales Share by Stent Type (2017-2027)
5.2.2. Global Biodegradable Stents Revenue and Revenue Share by Stent Type (2017-2027)
5.3. Coronary Artery Stents
5.3.1. Global Coronary Artery Stents Sales and Growth Rate (2017-2027)
5.4. Peripheral Artery Stents
5.4.1. Global Peripheral Artery Stents Sales and Growth Rate (2017-2027)
6. Biodegradable Stents Market, By Material
6.1. Introduction
6.2. Global Biodegradable Stents Sales, Revenue and Market Share by Material (2017-2027)
6.2.1. Global Biodegradable Stents Sales and Sales Share by Material (2017-2027)
6.2.2. Global Biodegradable Stents Revenue and Revenue Share by Material (2017-2027)
6.3. Polymer Based
6.3.1. Global Polymer Based Sales and Growth Rate (2017-2027)
6.4. Metal Based
6.4.1. Global Metal Based Sales and Growth Rate (2017-2027)
7. Biodegradable Stents Market, By End User
7.1. Introduction
7.2. Global Biodegradable Stents Sales, Revenue and Market Share by End User (2017-2027)
7.2.1. Global Biodegradable Stents Sales and Sales Share by End User (2017-2027)
7.2.2. Global Biodegradable Stents Revenue and Revenue Share by End User (2017-2027)
7.3. Hospitals
7.3.1. Global Hospitals Sales and Growth Rate (2017-2027)
7.4. Cardiac Catheterization Laboratories
7.4.1. Global Cardiac Catheterization Laboratories Sales and Growth Rate (2017-2027)
7.5. Ambulatory Surgery Centers
7.5.1. Global Ambulatory Surgery Centers Sales and Growth Rate (2017-2027)
8. Biodegradable Stents Market, By Region
8.1. Introduction
8.2. Global Biodegradable Stents Sales, Revenue and Market Share by Regions
8.2.1. Global Biodegradable Stents Sales by Regions (2017-2027)
8.2.2. Global Biodegradable Stents Revenue by Regions (2017-2027)
8.3. North America Biodegradable Stents by Countries
8.3.1. North America Biodegradable Stents Sales and Growth Rate (2017-2027)
8.3.2. North America Biodegradable Stents Revenue and Growth Rate (2017-2027)
8.3.3. North America Biodegradable Stents Sales by Countries (2017-2027)
8.3.4. North America Biodegradable Stents Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Biodegradable Stents Sales and Growth Rate (2017-2027)
8.3.5.2. United States Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Biodegradable Stents Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Biodegradable Stents Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Biodegradable Stents Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Biodegradable Stents by Countries
8.4.1. Europe Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.2. Europe Biodegradable Stents Revenue and Growth Rate (2017-2027)
8.4.3. Europe Biodegradable Stents Sales by Countries (2017-2027)
8.4.4. Europe Biodegradable Stents Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.6.2. UK Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.7.2. France Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Biodegradable Stents Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Biodegradable Stents Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Biodegradable Stents Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Biodegradable Stents Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.5.2. China Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.8.2. India Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Biodegradable Stents Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Biodegradable Stents Sales and Growth Rate (2017-2027)
8.6.2. South America Biodegradable Stents Revenue and Growth Rate (2017-2027)
8.6.3. South America Biodegradable Stents Sales by Countries (2017-2027)
8.6.4. South America Biodegradable Stents Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Biodegradable Stents Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Biodegradable Stents Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Biodegradable Stents Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Biodegradable Stents Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Biodegradable Stents Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Biodegradable Stents Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Biodegradable Stents Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Biodegradable Stents Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Biodegradable Stents Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. Boston Scientific, Inc.
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Biotronik
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. Kyoto Medical Corporation
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Elixir Medical Corporation
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. Biosensors International
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Terumo Europe NV
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. Ella CS
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
9.9. Sahajanand Medical Technologies
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Sales, Revenue and Market Share
10. Global Biodegradable Stents Market Competition, by Manufacturer
10.1. Global Biodegradable Stents Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Biodegradable Stents Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Biodegradable Stents Price by Manufacturer (2017-2017)
10.4. Top 5 Biodegradable Stents Manufacturer Market Share
10.5. Market Competition Trend
11. Biodegradable Stents Market Forecast (2027-2023)
11.1. Global Biodegradable Stents Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Biodegradable Stents Market Forecast by Regions (2027-2023)
11.2.1. North America Biodegradable Stents Market Forecast (2027-2023)
11.2.1.1. United States Biodegradable Stents Market Forecast (2027-2023)
11.2.1.2. Canada Biodegradable Stents Market Forecast (2027-2023)
11.2.1.3. Mexico Biodegradable Stents Market Forecast (2027-2023)
11.2.2. Europe Biodegradable Stents Market Forecast (2027-2023)
11.2.2.1. Germany Biodegradable Stents Market Forecast (2027-2023)
11.2.2.2. United Kingdom Biodegradable Stents Market Forecast (2027-2023)
11.2.2.3. France Biodegradable Stents Market Forecast (2027-2023)
11.2.2.4. Russia Biodegradable Stents Market Forecast (2027-2023)
11.2.2.5. Italy Biodegradable Stents Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Biodegradable Stents Market Forecast (2027-2023)
11.2.3. Asia-Pacific Biodegradable Stents Market Forecast (2027-2023)
11.2.3.1. China Biodegradable Stents Market Forecast (2027-2023)
11.2.3.2. Japan Biodegradable Stents Market Forecast (2027-2023)
11.2.3.3. Korea Biodegradable Stents Market Forecast (2027-2023)
11.2.3.4. India Biodegradable Stents Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Biodegradable Stents Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Biodegradable Stents Market Forecast (2027-2023)
11.2.4. South America Biodegradable Stents Market Forecast (2027-2023)
11.2.4.1. Brazil Biodegradable Stents Market Forecast (2027-2023)
11.2.4.2. Argentina Biodegradable Stents Market Forecast (2027-2023)
11.2.4.3. Columbia Biodegradable Stents Market Forecast (2027-2023)
11.2.4.4. Rest of South America Biodegradable Stents Market Forecast (2027-2023)
11.2.5. Middle East and Africa Biodegradable Stents Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Biodegradable Stents Market Forecast (2027-2023)
11.2.5.2. UAE Biodegradable Stents Market Forecast (2027-2023)
11.2.5.3. Egypt Biodegradable Stents Market Forecast (2027-2023)
11.2.5.4. Nigeria Biodegradable Stents Market Forecast (2027-2023)
11.2.5.5. South Africa Biodegradable Stents Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Biodegradable Stents Market Forecast (2027-2023)
11.3. Biodegradable Stents Market Forecast by Stent Type (2027-2023)
11.3.1. Global Biodegradable Stents Sales Forecast by Stent Type (2027-2023)
11.3.2. Global Biodegradable Stents Sales Market Share Forecast by Stent Type (2027-2023)
11.4. Biodegradable Stents Market Forecast by Material (2027-2023)
11.4.1. Global Biodegradable Stents Sales Forecast by Material (2027-2023)
11.4.2. Global Biodegradable Stents Sales Market Share Forecast by Material (2027-2023)
11.5. Biodegradable Stents Market Forecast by End User (2027-2023)
11.5.1. Global Biodegradable Stents Sales Forecast by End User (2027-2023)
11.5.2. Global Biodegradable Stents Sales Market Share Forecast by End User (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Biodegradable Stents Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|